Navigation Links
Clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen
Date:3/23/2009

Complimentary Continuing Education Virtual Lecture for Healthcare Professionals

VOORHEES, N.J., March 23 /PRNewswire/ -- The epidemiology of Clostridium difficile infection (CDI) is changing rapidly and has been marked by a significant increase in incidence and severity. Management of CDI can be challenging and guidelines for treatment and prevention are being updated. In order to effectively implement key strategies for reducing the incidence and severity of this virulent pathogen, it is crucial for primary care physicians to have current education on CDI.

To address the need for education on CDI, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture titled Clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen. The content for this virtual lecture was developed from a live satellite symposium held during Pri-Med East 2008. This activity is supported by an educational grant from ViroPharma Incorporated and is accredited for physicians.

Faculty for this continuing education virtual lecture include Frank Friedenberg, MD, MS (Epi), Associate Professor of Medicine in the Department of Gastroenterology at Temple University School of Medicine in Philadelphia, Pennsylvania; Stuart Johnson, MD, DTM&H, Associate Professor of Medicine at Loyola University Medical Center, Stritch School of Medicine in Maywood, Illinois, and Staff Physician at Hines VA Hospital in Hines, Illinois; and Linda M. Mundy, MD, Adjunct Assistant Professor in the Department of Community Health at Saint Louis University School of Public Health in St. Louis, Missouri, and Healthcare Consultant with LM Mundy, LLC, in Philadelphia, Pennsylvania.

Healthcare professionals can visit

SOURCE RMEI
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Interview with GI Experts: Discussions in Clostridium difficile
2. Clostridium difficile Infection: Best Strategies for Care of Older Adults
3. Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management
4. BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
5. Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients
6. Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
7. MRSA and C. difficile Infections Reduced by 50% in Hospital Study
8. New Report Shows High C-difficile Infection Rates in U.S. Hospitals
9. Advances in C. difficile research
10. APIC Launches First National C. Difficile Prevalence Study
11. APIC launches first national C. difficile prevalence study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... NY (PRWEB) May 24, 2013 The ... Cellular Dynamics International (CDI) exclusive license rights to ... and regenerative medicine applications. These cells are capable of ... heart, including cardiomyocytes, endothelial cells, and vascular smooth muscle ... therapeutic for damaged heart tissue. , The original agreement ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 On May ... seventh commencement ceremony of American University of Antigua ... in Lincoln Center. , This was the largest graduating ... ceremonies Dick Woodward, AUA’s Senior Vice President for Enrollment ... and Dr. Reza Sanii, Associate Dean of Students and ...
(Date:5/24/2013)... The creative flair and design talent of graduating ... of Textiles and Clothing (ITC) have won applause from ... on 22 May at The Mira Hong Kong. ... students, various knitwear producers and yarn suppliers, the annual ... outfits from 20 graduating students majoring in knitwear design. ...
(Date:5/24/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) ... than adults, with signs of serious complications seen just ... "Based on the latest results, it seems like ... Dr. Jane Chiang, senior vice president of medical affairs ... are appearing faster, and it appears to be at ...
(Date:5/24/2013)... News) -- Certain statins -- the widely used ... developing type 2 diabetes, a new study suggests. ... atorvastatin (brand name Lipitor), rosuvastatin (Crestor) and simvastatin ... almost 500,000 Ontario residents, researchers in Canada found ... low in patients prescribed statins. Still, people taking ...
Breaking Medicine News(10 mins):Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4Health News:AUA Celebrates Seventh Annual Commencement Ceremony 2Health News:PolyU Stages Knitwear Fashion Show 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 3Health News:Could Statins Raise Diabetes Risk? 2Health News:Could Statins Raise Diabetes Risk? 3
... a prestigious international healthcare and wellness center, will implement the ... Cypress Communications®. , ... Atlanta, GA ... healthcare and wellness center, will implement the C4 IP™ ...
... resident M. Michael Wolfe, MD, chief of the Gastroenterology ... research professor of physiology and biophysics at Boston University ... Top Doctors by Castle Connolly Medical Ltd. , The ... medical care, is a trusted and authoritative resource for ...
... been diagnosed with panic attacks or panic disorder have ... suffering a heart attack than the normal population, with ... published in Europe,s leading cardiology journal, the European ... , The study found that people who were younger ...
... WASHINGTON -- The U.S. Environmental Protection Agency should examine ... cause adverse health effects in humans, says a new ... this analysis, called a cumulative risk assessment, should consider ... effects as phthalates, instead of focusing on chemicals that ...
... prescribed for men with chronic prostatitis, a painful disorder ... significantly reduce symptoms in recently diagnosed men who had ... a clinical trial sponsored by the National Institute of ... the National Institutes of Health (NIH). The study is ...
... people know that how we live our lives effects our ... a healthy lifestyle? Why do health professionals like doctors ... public policy, health services, schools and education, the workplace, the ... support healthier living? For instance, can exercise help with addiction? ...
Cached Medicine News:Health News:MALO CLINIC Avoids Capital Expense and Gains Scalability with Hosted Unified Communications 2Health News:MALO CLINIC Avoids Capital Expense and Gains Scalability with Hosted Unified Communications 3Health News:MALO CLINIC Avoids Capital Expense and Gains Scalability with Hosted Unified Communications 4Health News:Boston University Medical Center gastroenterologist 2Health News:Panic attacks linked to higher risk of heart attacks and heart disease, especially in younger people 2Health News:Panic attacks linked to higher risk of heart attacks and heart disease, especially in younger people 3Health News:EPA should pursue cumulative risk assessment of phthalates and other chemicals 2Health News:EPA should pursue cumulative risk assessment of phthalates and other chemicals 3Health News:Common treatment for chronic prostatitis fails to reduce symptoms 2Health News:New Year starts with focus on healthy living 2Health News:New Year starts with focus on healthy living 3
(Date:5/24/2013)... 2013  An international roster of experts on malignant ... Santa Monica, Calif. , to discuss ... MPM, a rare form of cancer that results from ... lining of the chest. Hosted by UCLA ... 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant ...
(Date:5/24/2013)... , May 24, 2013  Heska Corporation (NASDAQ: HSKA, ... and specialty products, announced today that Dr. Robert ... and Jason Napolitano , executive vice president ... Marcum MicroCap Conference, which is being held May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...
(Date:5/24/2013)... , May 24, 2013 China Biologic Products, ... leading fully integrated plasma-based biopharmaceutical company in ... recently learned from a public announcement issued by Shanghai ... company listed on Shenzhen Stock Exchange, that on May ... ("Ms. Chan"), one of the shareholders of the ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4
... Sept. 26 Threshold,Pharmaceuticals, Inc. (Nasdaq: THLD ... trial of glufosfamide plus gemcitabine were presented at ... Spain. In the Phase 2 clinical trial ... of advanced pancreatic cancer, six-month and,one-year survival were ...
... Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced ... (Ibis), has been awarded a subcontract,of a National ... influenza,surveillance research through application of the Ibis T5000(TM) ... Ibis and the Lovelace,Respiratory Research Institute (LRRI) and ...
Cached Medicine Technology:Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 2Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 3Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 4Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies 2Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies 3Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies 4Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies 5
... Vision® Plus DR Urology System provides a ... the first dedicated digital urology imaging system ... was designed to use optimized geometry and ... intensifier for maximum anatomical coverage and sharper ...
Drew Scientific has been making leading edge, top quality CBC systems for over 15 years.,The Evolution offers all the features of the Excell 16 with the new addition of primary sample tube cap pier...
... ETS™ is a therapeutic, expandable turning surface ... ,INDICATIONS , Prevention and treatment of ... to turn, Large patients using a statuc ... relief surface, Patients whose body weight and ...
... The Maxxis™ 400 is a bariatric ... safety for individuals in the home care ... 1000 lbs. (or combined weight of 2) ... depending on frame size selected , ...
Medicine Products: